Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harris Gelbard

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The AIDS Reader|September 17, 2002
HIV-1-associated dementia: a basic science and clinical perspectiveThomas S Diesing, Susan Swindells, Harris Gelbard, et al.
Antimicrobial Agents and Chemotherapy|October 27, 2004
Effects of valproic acid coadministration on plasma efavirenz and lopinavir concentrations in human immunodeficiency virus-infected adultsRobert DiCenzo, Derick Peterson, Kim Cruttenden, et al.
Pattern Recognition|March 26, 2013
Directional Histogram Ratio at Random Probes: A Local Thresholding Criterion for Capillary ImagesNa Lu, Jharon Silva, Yu Gu, et al.
Antimicrobial Agents and Chemotherapy|June 25, 2008
Effects of minocycline and valproic acid coadministration on atazanavir plasma concentrations in human immunodeficiency virus-infected adults receiving atazanavir-ritonavirRobert DiCenzo, Derick R Peterson, Kim Cruttenden, et al.
Neuron|February 26, 2004
Activated protein C prevents neuronal apoptosis via protease activated receptors 1 and 3Huang Guo, Dong Liu, Harris Gelbard, et al.
Experimental Neurology|May 12, 2019
The second generation mixed lineage kinase-3 (MLK3) inhibitor CLFB-1134 protects against neurotoxin-induced nigral dopaminergic neuron lossElizabeth M Kline, Laura M Butkovich, Joshua M Bradner, et al.
Journal of Neurovirology|March 16, 2005
Productive infection of primary murine astrocytes, lymphocytes, and macrophages by human immunodeficiency virus type 1 in cultureJadwiga Nitkiewicz, Wei Chao, Galina Bentsman, et al.
Nanomedicine (London, England)|August 22, 2018
Modulating cellular autophagy for controlled antiretroviral drug releaseMidhun B Thomas, Divya Prakash Gnanadhas, Prasanta K Dash, et al.
Epilepsia Open|March 19, 2022
Clinical characteristics and outcomes after new-onset seizure among Zambian children with HIV during the antiretroviral therapy eraMathura Ravishankar, Ifunanya Dallah, Manoj Mathews, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The AIDS Reader|September 17, 2002
HIV-1-associated dementia: a basic science and clinical perspectiveThomas S Diesing, Susan Swindells, Harris Gelbard, et al.
Antimicrobial Agents and Chemotherapy|October 27, 2004
Effects of valproic acid coadministration on plasma efavirenz and lopinavir concentrations in human immunodeficiency virus-infected adultsRobert DiCenzo, Derick Peterson, Kim Cruttenden, et al.
Pattern Recognition|March 26, 2013
Directional Histogram Ratio at Random Probes: A Local Thresholding Criterion for Capillary ImagesNa Lu, Jharon Silva, Yu Gu, et al.
Antimicrobial Agents and Chemotherapy|June 25, 2008
Effects of minocycline and valproic acid coadministration on atazanavir plasma concentrations in human immunodeficiency virus-infected adults receiving atazanavir-ritonavirRobert DiCenzo, Derick R Peterson, Kim Cruttenden, et al.
Neuron|February 26, 2004
Activated protein C prevents neuronal apoptosis via protease activated receptors 1 and 3Huang Guo, Dong Liu, Harris Gelbard, et al.
Experimental Neurology|May 12, 2019
The second generation mixed lineage kinase-3 (MLK3) inhibitor CLFB-1134 protects against neurotoxin-induced nigral dopaminergic neuron lossElizabeth M Kline, Laura M Butkovich, Joshua M Bradner, et al.
Journal of Neurovirology|March 16, 2005
Productive infection of primary murine astrocytes, lymphocytes, and macrophages by human immunodeficiency virus type 1 in cultureJadwiga Nitkiewicz, Wei Chao, Galina Bentsman, et al.
Nanomedicine (London, England)|August 22, 2018
Modulating cellular autophagy for controlled antiretroviral drug releaseMidhun B Thomas, Divya Prakash Gnanadhas, Prasanta K Dash, et al.
Epilepsia Open|March 19, 2022
Clinical characteristics and outcomes after new-onset seizure among Zambian children with HIV during the antiretroviral therapy eraMathura Ravishankar, Ifunanya Dallah, Manoj Mathews, et al.
Pageof 1